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Aim To determine the lamellar body count (LBC) cutoff 
value for fetal lung maturity and to evaluate the clinical 
usefulness of LBC in predicting the severity of neonatal re-
spiratory distress syndrome (RDS).
Methods A prospective study was conducted from 2002 
until 2010. LBC was estimated in uncentrifugated amniotic 
fluid samples using Cell-Dyn 1800 analyzer. Amniotic fluid 
samples were obtained by amniocentesis or by punctur-
ing embryonic membranes during cesarean section. The 
presence of mild, moderate, and severe RDS was assessed 
by neonatologist.
Results A total of 313 patients with singleton pregnan-
cies (24-41 weeks) were included in the study and 294 met 
the inclusion criteria. RDS was diagnosed in 28 neonates – 
mild in 8, moderate in 10, and severe in 10. In premature 
neonates (<37 gestational weeks), significant differences 
in LBC were only found between the subgroup without 
RDS and the group with moderate and the group with se-
vere RDS (P < 0.001). In all neonates, significant differences 
were found between neonates without RDS and neonates 
with RDS. Using LBC cutoff value of ≥20,000/µL, sensitiv-
ity, specificity, and positive and negative predictive values 
of LBC in determining mature fetal lungs were 96%, 88%, 
45.6%, and 99.5%, respectively.
Conclusion This study suggests that LBC cutoff value of 
≥20,000/µL can predict pulmonary maturity and reduce 
the risk of neonatal respiratory distress syndrome.
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Respiratory distress syndrome (RDS) occurs in infants de-
livered before the completion of fetal lung maturation and 
remains a major cause of neonatal morbidity and mortality 
in premature infants (1). RDS affects approximately 1% of all 
live births, but 10 to 15% of all infants with a birth weight 
less than 2500 g (2). The risk of RDS is increased with pre-
maturity, but is also significant in infants born by electively 
scheduled cesarean delivery between 38 and 39 weeks of 
gestation (3). Therefore, the American College of Obstetri-
cians and Gynecologists recommends the documentation 
of fetal lung maturity for elective deliveries at less than 39 
weeks of gestation to avoid neonatal RDS (4). There are 
several antenatal tests for lung maturity. Evaluation is com-
monly based on laboratory measurements of the concen-
trations of particular components of pulmonary surfactant 
(4-7). Most of them are either complex, expensive, or with 
low diagnostic efficiency (8). Amniotic fluid lamellar body 
count (LBC) is one among various biophysical tests, based 
on measuring the concentration of pulmonary surfactant 
in amniotic fluid (9).
Lamellar bodies (LB) are storage form of surfactant with-
in type II pneumocytes and are actively secreted into the 
alveolar space and hence into the amniotic fluid (4). The 
size of LBs, similar to platelets, permits the use of a stan-
dard hematologic counter to quantify LB concentration in 
amniotic fluid samples. This technique quantitatively esti-
mates surfactant production and thus can predict the de-
gree of fetal lung maturation. Still, there are no clearly es-
tablished protocols and cutoff values for LBC that predict 
RDS (4). The maturity thresholds for LB vary due to differ-
ent factors, ie, centrifugation (leads to substantial loss of 
the LBs), sample contamination (meconium or platelets 
from the blood can be counted as LBs), and sample type 
(vaginal pool specimen containing mucus can artificially 
increase the LBC) (10,11). Depending on the protocols, the 
cutoff values of LBC that predict the absence of neonatal 
RDS can vary from 15 000 to even 80 000/µL (4,10,11). Also, 
the type of particle count analyzer used is critical in set-
ting the cutoff values, so it has been proposed to estab-
lish analyzer-specific references for LBC (1). The aim of our 
investigation was to evaluate the LBC cutoff value using 
Cell-Dyn 1800 analyzer (Abbott Diagnostics, Abbott Park, 
IL, USA) and evaluate the efficiency in predicting different 
grades of neonatal RDS.
MaTeRiaLs and MeThOds
A prospective study was conducted from the beginning 
of 2002 until the end of 2010 at the Department of Perina-
tology, University Hospital Rijeka. Amniotic fluid samples 
were obtained from women with singleton pregnancies 
(24-41 gestational weeks) who underwent transabdomi-
nal amniocentesis under ultrasound control for fetal lung 
maturity determination because of inevitable delivery and 
from those who underwent elective cesarean deliveries by 
puncturing visible embryonic membranes. In a 9-year pe-
riod, 26 473 deliveries were performed at our institution. 
We excluded those with gestational pathology that can in-
fluence fetal lung maturity (cases with premature rupture 
of membranes, oligohydramnios/hydramnios, and infants 
with major congenital or chromosomal abnormalities). A 
total of 313 women met the study criteria, agreed to par-
ticipate in the study, and provided written consent prior 
to the amniocentesis. The ethical approval was provided 
by ethics committees of the University Hospital Rijeka and 
University of Rijeka School of Medicine. Out of 313 women, 
19 were excluded because the deliveries occurred more 
than 7 days after amniocentesis or were done in other in-
stitutions so medical charts from the delivery were not 
available.
Gestational age was calculated from the last menstrual 
period and confirmed by ultrasound measurement dur-
ing the first 20 weeks of pregnancy. Samples containing 
5 mL of amniotic fluid were immediately transported to 
the clinical laboratory in a capped plastic syringe and an-
alyzed according to an established protocol (10,12). LBC 
was estimated in uncentrifugated amniotic fluid samples 
using the Cell-Dyn 1800 analyzer and its platelet chan-
nel. All samples containing blood or meconium were re-
jected.
The neonatal respiratory status and existence of RDS were 
reviewed by attending neonatologists, who had not been 
informed about the concentration of LBs. All neonates 
were divided into four groups according to clinical symp-
toms of RDS and therapy measures: group A – without 
symptoms, group B – mild RDS (expiratory grunting, transi-
tional tachypnea, O
2 in therapy), group C – moderate RDS 
(prior symptoms + bluish color of the skin, chest wall retrac-
tion, in therapy O2>40% and/or continuous positive airway 
pressure, sometimes surfactant), and group D – severe 
RDS (prior symptoms + cyanosis, apnea, therapy includes 
all intensive supportive measures, surfactant, mechanical 
ventilation). Diagnosis of moderate and severe RDS was 
confirmed by findings on chest radiographs. The special 
subgroup of premature deliveries (<37 weeks) was ex-
tracted from the group A with a purpose to compare 
this group with the groups B, C, and D.
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Statistical analysis was performed using MedCalc Soft-
ware (Mariakerke, Belgium), version 11.3.3.0. We used χ2 
test for values assessed on a nominal scale and Kruskal-
Wallis ANOVA for non-normally distributed data. Mann-
Whitney U test was used for subsequent comparison be-
tween different groups. The cutoff value for predicting 
a high likelihood of RDS was derived from the receiver-
operating characteristic (ROC) curve. We also determined 
Spearman rank correlation coefficient between LBC and 
gestational age and calculated sensitivity, specificity, pos-
itive predictive value, and negative predictive value for 
LBC in predicting fetal lung maturity. Also, the likelihood 
ratios for positive (LR+) and negative tests (LR-) were de-
termined. For all tests, a value of P < 0.05 was considered 
significant.
ResuLTs
Nineteen out of 313 women were excluded either be-
cause their deliveries occurred more than 7 days after 
amniocentesis or their medical charts were not available. 
Among 294 patients who met the study criteria, there 
were 43% nuliparous women. Median maternal age was 
30 years (range 16-45) and median gestational age was 
37 weeks (range 24-41). Most of them (73%) were de-
livered by cesarean section. Advanced gestational age 
was associated with higher LB concentration (Spearman 
rank correlation coefficient; r = 0.600, P < 0.001) (Figure 1). 
A total of 47% of neonates were female (n = 142), medi-
an weight was 2585 g (range 550-5620), and 13 out of 
294 had 5-minute Apgar score <7. RDS was diagnosed 
in 28 (9.5%) neonates and all of them were premature – 
8 neonates had mild, 10 had moderate, and 10 had se-
vere RDS. All 3 neonatal deaths due to acute RDS were in 
the group of neonates with the most severe clinical form 
of RDS (24 weeks – LBC 3000/µL; 24 weeks – LBC 2000/
µL; 31 weeks – LBC 1000/µL). We found significant differ-
ences between neonates with (group B, C, and D) and 
without RDS (group A) in gestational age, birth weight, 
5-minute Apgar score, and mode of delivery (Table 1). 
We also found significant differences in LBC between the 
neonates without RDS and all three groups of neonates 
with various severities of RDS, but there were no signifi-
cant differences between the groups with mild, moder-
ate, and severe neonatal RDS (Table 2). In premature de-
liveries <37 gestational weeks, significant differences in 
amniotic fluid LBC were only found between the sub-
group without RDS and the groups with moderate and 
severe RDS (P < 0.001). The area under the ROC curve for 
LBC in RDS prediction in neonates was 0.97 (95% confi-
dence interval, 0.94-0.99) (Figure 2). The sensitivity, speci-
ficity, and positive and negative predictive values for LBC 
value ≥20,000/µL in predicting fetal lung maturity were 
TaBLe 2. amniotic fluid lamellar body counts according to 
the presence and severity of neonatal respiratory distress 
syndrome (Rds)
Rds (number of cases)
LBC × 1000/µL 
median (range)
Gestational age 
median (range)
Group A (n = 266) 55.5 (4-384)* 37 (30-41)
Without, gestation <37 weeks
(n = 99)
26 (2-271)† 35 (30-36)
Group B (n = 8) 12 (3-33) 32.5 (30-36)
Group C (n = 10)  5.5 (1-10) 28 (27-33)
Group D (n = 10)  3.5 (1-8) 29.5 (24-32)
*significant differences in amniotic lamellar body counts (LBC) be-
tween the group a and other three groups of neonates with Rds.
†significant differences in amniotic LBC between the subgroup of 
premature neonates (<37 weeks) without Rds and the groups C and d.
TaBLe 1. Characteristics of neonates with (n = 28) and without 
respiratory distress syndrome (Rds) (n = 266)
Characteristics Without Rds With Rds P
Gestational age in 
weeks
  37 (30-41)*   30 (24-37)* <0.001†
Birth weight in grams 2690 (660-5620)*1240 (550-3580)* <0.001†
5-min Apgar score <7 
(n, %)
  24 (9)   20 (71) <0.001‡
Female sex (n, %)  127 (47)   15 (53)  0.698‡
Cesarean section (n, %) 188 (70)   26 (92)  0.022‡
*Median (range).
†Mann-Whitney test.
‡χ2 test.
FiGuRe 1. Median values and range of lamellar body counts in 
amniotic fluid according to gestational age (n = 294).
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96%, 88%, 45.6%, and 99.5%, respectively. The likelihood 
ratio for a positive test was 8.02 and for a negative test 
was 0.04.
disCussiOn
The cutoff value for LBC in predicting fetal lung maturity 
in our study was ≥20,000/µL. Because of different types 
of count analyzer and various protocols, different authors 
propose different cutoff values (13-15). At our institution, 
we established a protocol for LBC testing using Cell-Dyn 
1800 automatic analyzer. We did not collect amniotic fluid 
samples from the vagina and samples were free of blood 
and meconium, and more importantly, not centrifugat-
ed before the analysis, because this can considerably de-
crease LBC (6).
We demonstrated that advancing gestational age led to 
higher LB concentrations, with significant differences in 
amniotic fluid LBC between healthy neonates and those 
with RDS. This finding confirms gestational age as an in-
dependent factor with important influence on amniotic 
fluid LBCs. The group of neonates with RDS had signifi-
cantly lower gestational age, birth weight, and 5-minute 
Apgar score than healthy neonates. Significant differences 
in LBCs were found between the neonates without RDS 
and all three groups of neonates with various severities of 
RDS, but there were no significant differences between 
the groups with mild, moderate, and severe RDS. Because 
the neonates with RDS were all premature, we wanted to 
compare them with a subgroup of premature newborns 
derived from the group of healthy neonates without RDS 
(group A). The antenatal amniotic fluid LBC method was 
able to differentiate between the neonates without RDS 
and the neonates who will develop moderate and/or se-
vere forms of acute RDS. However, based on our results 
that more severe forms of RDS were accompanied by low-
er median LBC, but with no significant differences in LBC 
between the three groups with RDS, we can only hypoth-
esize that amniotic fluid LBC cannot differentiate between 
moderate and severe forms of RDS. Such result may be a 
consequence of a relatively small number of cases with 
mild, moderate, and severe RDS. We are convinced that 
clinically significant result of LBC≥20,000/µL of amniotic 
fluid as a cutoff value can predict pulmonary maturity with 
high sensitivity and specificity and thus reduce the possi-
bility of moderate and severe RDS. The calculated LBC cut-
off value was lower than the majority of reported cutoff 
values in literature, probably because we classified acute 
neonatal RDS in three grades according to severity (4,8). 
LBC cutoff value of ≥20,000/µL can predict pulmonary ma-
turity and reduce the risk of the neonatal RDS. Amniotic 
fluid LBC performed on cell-counting equipment available 
in most clinical laboratories is a simple, rapid, inexpensive, 
and the most practical antenatal method for the efficient 
evaluation of fetal lung maturity and prediction of neona-
tal RDS.
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